atovaquone has been researched along with Toxoplasmosis, Congenital in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chorlton, SD | 1 |
De Souza, W; Portes, JA | 1 |
Oz, HS; Tobin, T | 1 |
Petersen, E | 1 |
1 review(s) available for atovaquone and Toxoplasmosis, Congenital
Article | Year |
---|---|
Prevention and treatment of congenital toxoplasmosis.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Female; Food Contamination; Humans; Pregnancy; Pregnancy Complications, Infectious; Toxoplasma; Toxoplasmosis, Congenital | 2007 |
3 other study(ies) available for atovaquone and Toxoplasmosis, Congenital
Article | Year |
---|---|
Adjunctive bradyzoite-directed therapy for reducing complications of congenital toxoplasmosis.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Brain; Chorioretinitis; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eye; Humans; Infant; Infant, Newborn; Mice; Models, Biological; Recurrence; Spiramycin; Toxoplasma; Toxoplasmosis, Animal; Toxoplasmosis, Cerebral; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular | 2019 |
Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.
Topics: Antiprotozoal Agents; Atovaquone; Brazil; Cell Line; Genetic Markers; Green Fluorescent Proteins; Humans; Life Cycle Stages; Parasitology; Pyrimethamine; Toxoplasma; Toxoplasmosis, Congenital | 2019 |
Atovaquone ameliorate gastrointestinal toxoplasmosis complications in a pregnancy model.
Topics: Analysis of Variance; Animals; Anti-Infective Agents; Atovaquone; Disease Models, Animal; Female; Gastrointestinal Tract; Hepatitis; Hyperalgesia; Immunohistochemistry; Mice; Pancreatitis; Pregnancy; Toxoplasmosis, Congenital | 2012 |